Communications Biology (Mar 2023)

Protection against Omicron BA.1/BA.2 severe disease 0–7 months after BNT162b2 booster

  • Ofra Amir,
  • Yair Goldberg,
  • Micha Mandel,
  • Yinon M. Bar-On,
  • Omri Bodenheimer,
  • Laurence Freedman,
  • Sharon Alroy-Preis,
  • Nachman Ash,
  • Amit Huppert,
  • Ron Milo

DOI
https://doi.org/10.1038/s42003-023-04669-6
Journal volume & issue
Vol. 6, no. 1
pp. 1 – 7

Abstract

Read online

Patient data from the Israeli Ministry of Health demonstrates that a 3rd dose of BNT162b2 is effective in reducing Omicron BA.1/BA.2 severe disease and does not wane over the seven month study period as well as that a fourth dose further improves the protective features of vaccination.